Tohoku University Technology: Diagnostic Method for Urogenital System Cancer: T07-005
It is possible to achieve a more accurate diagnosis than the diagnosis based on PSA as an indicator for prostate cancer.
Traditionally, PSA has been known as an early diagnostic marker for prostate cancer. However, PSA levels can rise not only in prostate cancer but also in benign prostatic disease (BPD), lacking specificity. The present invention relates to a diagnostic method for urogenital system cancers based on the level of haptoglobin β chain or its fragments, which are specifically bound by RM2 antibodies isolated from tissues or body fluids of the subject.
- Company：Tohoku Techno Arch Co., Ltd.
- Price：Other
